Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT: NCT04097145 · RECRUITING

NCT IDNCT04097145
StatusRECRUITING
Start Date2019-12-11
Completion2031-12-31
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑